Cadent Therapeutics has assembled a world-class team of executives, scientific advisors and board members who have made treating neurological disease their life’s work. Our team is committed to bringing new life-changing medicines to the people who need them most.

Executive Team

Michael Curtis, PhD
President and CEO

Tim Piser, PhD
Chief Scientific Officer

Bob Dagher, MD
Chief Medical Officer

Gregg Keaney, PhD
Vice President of Product Development

Board Members

Peter Barrett, PhD
Chairman of the Board
Atlas Venture

David Grayzel, MD
Atlas Venture

William Koster, PhD

Richard Horan
Slater Technology Fund

Franz Hefti, PhD

James Bristol, PhD

Clinical Advisors: Spinocerebellar Ataxia

Jeremy Schmahmann, MD
Director, Ataxia Unit
Department of Neurology
Massachusetts General Hospital

Christopher M. Gomez, MD, PhD
Albina Y. Surbis Professor
Department of Neurology
The University of Chicago

Susan Perlman, MD
Clinical Professor of Neurology
Director, Ataxia Center and HD Center of Excellence
Department of Neurology

Vikram Shakkottai, MD, PhD
Associate Professor
Department of Neurology
Department of Molecular and Integrative Physiology
University of Michigan

Sheng-Han Kuo, MD
Assistant Professor
Department of Neurology
Columbia University

Clinical Advisors: Essential Tremor

Dietrich Haubenberger, MHSc, MD
Director, Clinical Trials Unit
NINDS Intramural Research Program
National Institutes of Health
Bethesda, MD

Rodger J. Elble, MD, PhD
Director, Parkinson Disease and Movement Disorders Clinic
SIU Medicine
Springfield, IL

Elan D. Louis, MD, MS
Chief, Division of Movement Disorders (Neurology)
Associate Chair for Outpatient Clinical Research (Neurology)
Professor of Neurology and Epidemiology
Departments of Neurology and Chronic Disease Epidemiology
Yale University

Sheng-Han Kuo, MD
Assistant Professor
Department of Neurology
Columbia University

William Ondo, MD
Professor of Neurology
Director, Movement Disorders Clinic, Methodist Neurological Institute
Director, Restless Legs Syndrome Quality Care Center
President, Tremor Research Group
Methodist Research Institute and Weill Cornell Medical School

Investors & Partners

atlas venture
slater technology fund